Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11666638 Glycotargeting therapeutics

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 6, 2023

0

Patent Application Number

167237740

Date Filed

December 20, 2019

0

Patent Citations

US Patent 9518087 Erythrocyte-binding therapeutics

0

US Patent 10940209 Glycotargeting therapeutics

0

US Patent 10946079 Glycotargeting therapeutics

0

US Patent 10953101 Glycotargeting therapeutics

0

US Patent 7132475 Block copolymers for multifunctional self-assembled systems

0

US Patent 7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots

0

US Patent 7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10

0

US Patent 7192582 Human monoclonal antibodies to FC alpha receptor (CD89)

0

...

Patent Primary Examiner

Thea D'Ambrosio

0

Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11666638 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool